Skip to main content
Donate

What is Angelman Syndrome?

What is FAST?

FAST is the largest non-governmental funder of Angelman syndrome research, and we take this responsibility seriously. Since 2011, we’ve committed over $20 million to life-changing research.

Make a Donation

Our sole mission
is to cure Angelman
Syndrome.

Our sole mission
is to cure Angelman
Syndrome.

What is Angelman Syndrome?

Angelman syndrome (AS) is a rare disorder caused by the loss of function of a single gene and affects approximately 500,000 people worldwide.

Symptoms typically become noticeable around the age of 6-12 months and may include difficulty suckling and eating, gastrointestinal issues, delayed crawling and babbling, balance and motor impairment, and seizures. Some individuals never walk, and most do not speak. And while they require continuous care, they have a normal life expectancy and a distinctly happy demeanor, characterized by frequent laughing, smiling and excitability.

Understanding Angelman Make a Donation

What isAngelman Syndrome?

Angelman syndrome (AS) is a rare disorder caused by the loss of function of a single gene and affects approximately 500,000 people worldwide.

Symptoms typically become noticeable around the age of 6-12 months and may include difficulty suckling and eating, gastrointestinal issues, delayed crawling and babbling, balance and motor impairment, and seizures. Some individuals never walk, and most do not speak. And while they require continuous care, they have a normal life expectancy and a distinctly happy demeanor, characterized by frequent laughing, smiling and excitability.

Understanding Angelman

Amelia's Story

My name is Amelia Beatty, and this is my son Orion. As with all parents when their child is diagnosed with AS, my husband and I were devastated. I remember very clearly the geneticist giving us a long list of all the things that Orion would never be able to do. Our dreams for Orion were crushed. A friend connected me with another mom whose child also has AS, and she told me about FAST. “Angelman syndrome is treatable,” she said. “FAST is funding research to find a cure.” I dared to hope for a brighter future for Orion.

https://youtu.be/Hyqrqdk-GBM

What Makes FAST Unique?

Focused on a Cure

Scientists know what causes AS and have been able to reverse it in mouse models, and we’ve found multiple pathways to a cure.

A Better Future for Our Kids

FAST is almost entirely volunteer-run. We are a group of passionate parents committed to bringing life-changing treatments to all individuals with AS, regardless of genotype or age.

Connecting the Brightest Minds

FAST has set the research agenda for AS by bringing together a multidisciplinary team of more than two-dozen scientists from top research universities and pharmaceutical companies.

How FAST Began

When Founder Paula Evans received the diagnosis that her daughter, Ainsley, had Angelman syndrome and that there was no treatment or hope for a cure, all she could think was,

Why not?
There is always hope.

FAST was formed three years later by a group of parents with expertise in the fields of science, medicine, finance, law, entrepreneurship, management and entertainment. We adopted a clear and concise mission to bring practical treatments into current medical practice as quickly as possible. We developed a unique funding philosophy that set us apart from similar nonprofit organizations and placed us on a solid trajectory to identify therapeutics and a cure for AS.

Our History

How FASTBegan

When Founder Paula Evans received the diagnosis that her daughter, Ainsley, had Angelman syndrome and that there was no treatment or hope for a cure, all she could think was,

Why not?
There is always hope.

FAST was formed three years later by a group of parents with expertise in the fields of science, medicine, finance, law, entrepreneurship, management and entertainment. We adopted a clear and concise mission to bring practical treatments into current medical practice as quickly as possible. We developed a unique funding philosophy that set us apart from similar nonprofit organizations and placed us on a solid trajectory to identify therapeutics and a cure for AS.

Our History

Stay informed about Angelman syndrome breakthroughs, new research initiatives, and stories of hope and resilience.

Now is the Time
for Action.

FAST’s Roadmap to a Cure is bold, ambitious, and, with your help, achievable. Because we know exactly what causes AS and it has already been cured in the laboratory, an investment in FAST is an investment of global proportion.

Our findings will change the lives of people with Angelman syndrome and, potentially, millions more who have related disorders like autism and Alzheimer’s disease.

Make a Donation Other Ways to Give Facebook Twitter Linkedin Youtube Instagram

© 2021 FAST | All Rights Reserved.

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.